$
1. 24
+0.01
+0.813%
$
60.13M Market Cap
- P/E Ratio
- Div Yield
36,360 Volume
-0.32 Eps
$ 1.23
Previous Close Investors:
Want to track ENTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Entera Bio Ltd. (ENTX) Statistics
Valuation metrics
Market Cap 60.13M
Enterprise value 56.94M
Trailing P/E (ttm) -4.75
Forward P/E -2.4
PEG ratio 0.03
Price/Sales (ttm) 1,547.08
Price/Book (mrq) 5.5
Enterprise Value/Revenue 1,285.5
Enterprise Value/EBITDA -4.61
Overview
Shares outstanding 46.18M
Float 32.24M
Shares short 192.78K
% Held by insiders 0.21%
% Held by institutions 0.17%
Average volume (10 days) 45.82K
Average volume (90 days) 178.75K
Price summary
52-Week low 0.91
52-Week high 3.22
Beta 1.55
50-Day moving average 1.22
200-Day moving average 1.48
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.05%
Operating margin -274.5%
Operational effectiveness
Return on assets -0.94%
Return on equity -0.88%
Income Statement
Revenue (ttm) 42K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) 9K
EBITDA -11.5M
Net income to common (ttm) -11.44M
Diluted EPS (ttm) -0.26
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 7.11M
Total cash per share (mrq) 0.09
Total debt (mrq) 490K
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 7.93%
Book value per share (mrq) 0.22
Cash Flow
Cash flow statement -7.37M
Levered free cash flow (LFCF) -11.44M
